Strategic program management and operations consulting.
Providing interim executive leadership for biopharma research and development
Approach
Crestline Therapeutics Consulting makes use of its over 22 years experience in biopharma research and development to deliver high quality and innovative results. Primarily focused on IND-enabling through Phase 2 clinical stages of development, we support your program’s needs by filling in the gaps and collaborating with existing teams. Strategic program management and tactical operations services available.
Services
-
Program Management
-
Development Strategy
-
Clinical Operations
Elizabeth Wagner, MS, MBA, MA
-
Elizabeth is the former COO of Constant Therapeutics where she led all strategic operational dealings for the company, including single-handedly executing manufacturing, preclinical development, clinical development, regulatory administration and other strategic initiatives. Elizabeth successfully coordinated all preclinical and clinical research activities leading to 3 Phase 2 assets (COVID-19, DMD and stroke), and positively progressed an oral formulation program for a peptide through GMP production. She helped secure $850k from a coalition of patient organizations to fund an Epidermolysis Bullosa orphan program and supported a potential $30M out-licensing deal for a small molecule asset to a VC firm.
Elizabeth's previous experience includes Corporate Development at Cubist Pharmaceuticals, Pipeline and Portfolio Planning at Genentech, and Clinical Research at Genzyme. She received her B.S. in pre-medicine from the University of Notre Dame, her M.A. in Clinical Investigation from Boston University School of Medicine, and her M.B.A. and M.S. from MIT. Elizabeth loves the mountain lifestyle, including skiing, mountain biking and hiking, and she enjoys traveling to experience different cultures.